Pass It On Trial

Pass It On Trial Convalescent plasma clinical trial for COVID-19. This treatment, convalescent plasma, comes from the blood of patients who have recovered from COVID-19.

The Passive Immunity Trial for Our Nation (Pass It On) is a clinical trial looking to see if a potential treatment, convalescent plasma, might help patients who are sick and hospitalized with COVID-19 recover faster. These patients have developed antibodies that help fight the virus and will be given to sick patients who are in the hospital. Participation in this research study is completely voluntary and it is taking place in 30 sites across the United States.

Address

Nashville, TN

Telephone

+16153438010

Website

Alerts

Be the first to know and let us send you an email when Pass It On Trial posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Pass It On Trial:

Shortcuts

Share

Category

A research study on convalescent plasma to treat hospitalized COVID-19 patients

Vanderbilt University Medical Center is leading a research study to determine if convalescent plasma is an effective treatment for patients who are hospitalized with COVID-19.

The Passive Immunity Trial for Our Nation (Pass It On) is a clinical trial testing a treatment for COVID-19 patients who are hospitalized. This treatment, convalescent plasma, comes from the blood of patients who have recovered from COVID-19. These patients have developed antibodies that help fight the virus and will be given to sick patients who are in the hospital. Participation in this research study is completely voluntary.

This study is currently enrolling 1,000 patients at 50 locations around the United States. Study participants may see an improvement in their condition, including survival, faster recovery time, or less need for intensive care. Society may benefit as well from learning more about the use of convalescent plasma to treat COVID-19.

Essential workers, racial and ethnic minorities, and those with underlying health conditions are being impacted the most by COVID-19. It is crucial that researchers find a treatment that helps everyone, especially people most affected by this virus.